Tirzepatide (10mg / 20mg / 30mg / 50mg) — Research Peptide

Tirzepatide (CAS 2023788-19-2) is a synthetic research peptide supplied by Eclipse Peptides as a high-purity reference compound for in-vitro laboratory study. It is characterized by the molecular formula C225H348N48O68 and a molecular weight of 4813.45 g/mol, provided as a white lyophilized powder at a minimum purity of >99%.

Tirzepatide is studied in the context of metabolic research and remains an active area of scientific investigation. Eclipse supplies Tirzepatide strictly as a reference material for research applications. Each batch is third-party tested and ships with a Certificate of Analysis. Store lyophilized at 2–8°C.

This product is for in-vitro research use only. It is not a drug, supplement, or medical product and is not intended for human or animal consumption.

Tirzepatide is a synthetic peptide currently being studied for its activity at the GIP and GLP-1 receptors. It remains an active area of scientific research and investigation.

Tirzepatide has been investigated in preclinical and clinical research exploring dual incretin receptor signaling pathways related to metabolism and energy regulation.

A batch-specific Certificate of Analysis is included with every shipment of this compound. Historical batch COAs are available from our documentation hub.